Mehfooz Dawa App: Check Medicine Price and Authenticity

Last updated: 10 November 2026.

The Mehfooz Dawa app is the Drug Regulatory Authority of Pakistan at your pharmacy counter: scan the 2D barcode printed on a medicine pack and the app shows whether the product is registered and what its official price is, in seconds, before you pay. DRAP is urging consumers to use it as the frontline defence against counterfeit medicines, overpricing and black marketing, and the timing is deliberate, because the barcode mechanism became mandatory on 1 October and the national track and trace system for medicines went operational on 9 October. With around 800 pharmaceutical companies and more than 90,000 medicines registered with the regulator, the app now covers most of what a Pakistani pharmacy shelf holds, and this guide explains exactly how it works, what it protects you from, and the workarounds when a scan fails.

What the Mehfooz Dawa App Does

The consumer-facing app is the visible half of a regulatory machine that took a decade to assemble. Pakistan first proposed a medicine barcode system in 2015, the federal cabinet approved it in 2017, and administrative delays stalled implementation for years until Health Minister Mustafa Kamal took notice and forced a deadline, with DRAP setting 1 October 2026 as the cut-off for the barcode mechanism and the track and trace system going live on 9 October. Manufacturers and importers must now place standardised 2D barcodes and serialisation data on packaging, more than 86,000 medicines are registered under the track and trace side, and the Ministry of National Health Services says the digital push is part of a broader commitment to safe and quality-assured medicines. For buyers, the practical meaning is simple: the pack in your hand is no longer just a box, it is a database record you can interrogate.

Why Counterfeit Medicine Needed This Fix

The problem the app attacks is bigger than occasional fraud. Global health regulators have long estimated that roughly one in ten medicines in developing markets is fake or substandard, and Pakistans share of the problem is worse for life-saving categories, which is why DRAP continues to issue alerts about counterfeit, substandard, adulterated and unregistered products. A fake pack fails in one of two ways, either it contains nothing active, which turns a treatable illness into a progressing one, or it contains the wrong dose or contaminants, which introduces its own risks, and both failure modes are invisible to an ordinary buyer holding a well-printed box. Overpricing is the quieter cousin of counterfeiting, where genuine medicine is sold above the registered price and the consumer has no reference point, and the app closes that gap too by putting the official figure on the counter between buyer and cashier. Verification shifts the burden of proof from the patient to the pack, which is the only direction that works at scale, and it does so without asking any consumer to become a pharmaceutical expert.

How to Use the App at the Pharmacy

The workflow takes under a minute once the habit forms. Ask for the medicine, then before paying, open the app and scan the 2D barcode printed on the pack, and the screen returns the registration details and the official price. Compare three things: the product name on screen against the pack, the batch and expiry presentation against the label, and the displayed price against what the counter is charging. If everything matches, pay, and keep the receipt, because the receipt is your evidence if a later batch problem triggers a recall. If the pack carries no barcode, or the scan returns nothing, or the price on screen is lower than the counter price, stop and treat it as a hard signal: ask the pharmacist for an alternative pack, buy only from licensed outlets as the regulator advised in its 5 November alert, and report the seller to the provincial drug control machinery. The app needs a smartphone and data, so for purchases on behalf of elders, the scan should happen at the counter, not at home after the medicine is already consumed.

Where Price Verification Fits in the Household Budget

Medicine pricing verification lands in the same consumer-habit family as checking regulated prices elsewhere in the economy, and the pattern is now national: fuel boards change daily, utility tariffs move seasonally, and every rupee of gap between the notified price and the charged price compounds across a household month. Readers already running that discipline can keep the daily reference set together, the petrol price in Pakistan today for fuel, the gold rate for November for jewellery purchases where purity and rate both need verification, and the Daraz 11.11 sale guide for online purchases where listed-versus-actual pricing is the same game by another name. The pharmacy version is simply the newest member of the family, and the most important one, because a wrong fuel price costs money while a wrong medicine costs health. Families managing chronic conditions should standardise the scan at every refill, since repeat prescriptions are where quiet overcharging accumulates fastest.

A Practical Buyer Checklist for Every Purchase

A fixed checklist turns the app from a novelty into a routine that survives busy days. Step one, buy from a licensed pharmacy in the first place, because the app verifies a pack but no app fixes an unlicensed seller. Step two, scan before paying, not after, and make the scan in front of the pharmacist so any discrepancy is resolved on the spot with an alternative pack rather than at home over an open box. Step three, read the registration details on screen against the physical label, matching the product name, strength and pack size, because a scan that resolves to a different strength is its own kind of problem. Step four, compare the official price against the billed price and question any gap immediately, keeping the receipt as evidence. Step five, check the physical condition of the pack, the seal, the blister integrity and the expiry, since verification data cannot see a compromised blister. Families buying for elderly parents or chronic conditions should photograph the scanned screen with the receipt, a ten-second habit that builds the paper trail a later complaint or recall claim will need. None of this adds more than a minute to a purchase, and together the steps close nearly every gap a counterfeit seller relies on.

Consumer Safety Alerts Continue Alongside

The app does not replace the regulators alert system, it rides on top of it. DRAP continues issuing alerts on counterfeit, substandard and unregistered products, including the 5 November advisory telling consumers to buy only from authorised or licensed outlets and to check authenticity and condition before purchase, and the track and trace data now lets the regulator act batch by batch rather than product by product, which is what makes recalls surgical instead of panic-driven. The twin-city fuel dispute this month showed how quickly a verification gap becomes a consumer-rights story, and our coverage of the PCRWR bottled water report follows the same regulator-versus-market arc for drinking water, where brand-level results name names. The lesson across all three is identical: the state now publishes verification data, the burden of checking has shifted to the buyer, and the buyers who check are the ones the enforcement system works for.

Limitations and What Comes Next

Honest limits keep expectations calibrated. The app verifies registration and price, not storage conditions, so a genuine pack kept in heat or humidity can still degrade, which is why the condition-of-pack advice in every DRAP alert matters as much as the scan. Packs manufactured before the barcode deadline may circulate for a while without scannable codes, and imported or donor-supplied medicines can sit outside the registration net, so a failed scan means stop-and-ask rather than automatic proof of a fake. Rural pharmacies with weak data connectivity limit the apps reach, and counterfeiters eventually copy codes, which is why serialisation matters more than the barcode picture alone. The trajectory, though, is one-way: more packs under serialisation, more batch-level traceability, and a regulator with the data to act on the first complaint rather than the hundredth. For consumers the ask is small, one scan per purchase, and the collective effect is a market where fakes lose their camouflage, one pharmacy and one receipt at a time.

Frequently Asked Questions

What is the Mehfooz Dawa app?

It is the Drug Regulatory Authority of Pakistan consumer app that lets you scan the 2D barcode on a medicine pack to see the registered product details and the official DRAP price before you buy.

How many medicines are registered on the system?

Around 800 pharmaceutical companies and more than 90,000 medicines are registered with DRAP, and over 86,000 medicines are covered under the track and trace system.

When did the track and trace system start?

The centralised track and trace system for medicines became operational on 9 October 2026, and the barcode mechanism became mandatory from 1 October 2026.

What should I do if a medicine pack does not scan?

Treat it as a red flag, ask the pharmacist for an alternative pack, buy only from licensed outlets as DRAP advised in its 5 November alert, and report the seller to provincial drug control authorities.

Does the app guarantee the medicine is not fake?

It verifies registration and official price, which catches unregistered and overpriced products, but storage condition and pre-deadline packs still need the usual checks, so scan plus inspection remains the right habit.

Is there any reward for reporting a fake medicine?

The app sends verification data to DRAP so regulators can trace and recall batches; consumer rewards for reporting are not part of the announced system, so rely on the official channels for any complaint.

App guidance and consumer alerts are published on the reporting that carried the DRAP announcement, and this page will be updated as the registered-medicine count and enforcement actions grow.